Shanghai Shyndec Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2024: USD 308.98 M

Shanghai Shyndec Pharmaceutical Co., Ltd. Operating Cash Flow is USD 308.98 M for the year ending December 31, 2024, a 27.51% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Shanghai Shyndec Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2023 was USD 242.31 M, a -41.44% change year over year.
  • Shanghai Shyndec Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 413.81 M, a 56.54% change year over year.
  • Shanghai Shyndec Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 264.35 M, a 10.60% change year over year.
  • Shanghai Shyndec Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 239.02 M, a 31.05% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities